Clinical laboratory testing: what is the role of tilt-table testing, active standing test, carotid massage, electrophysiological testing and ATP test in the syncope evaluation?

Abstract:

:The first step in the diagnostic evaluation of patients with suspected syncope begins with an "initial evaluation" consisting of careful history taking, physical examination including orthostatic blood pressure measurement and electrocardiogram. However, even in expert centers the diagnostic yield of this "initial evaluation" is only approximately 50%. In the remaining cases in which a satisfactory diagnosis is either unknown or uncertain after initial assessment, additional clinical testing is needed. This article reviews the role of some of the more commonly used additional diagnostic tests, including: tilt-table testing, the active standing test, carotid sinus massage, electrophysiological testing, and the adenosine triphosphate (ATP) test. The role of angiography, exercise testing and imaging is noted briefly. Other clinical laboratory investigations, such as ambulatory ECG monitoring, are examined in other papers in this issue. In brief, clinical laboratory tests, carefully interpreted, may be useful in the evaluation of the basis of suspected syncope. However, these tests should be selected carefully and performed based on the pre-test probability inferred from the initial examination, and the less invasive tests should be used first.

journal_name

Prog Cardiovasc Dis

authors

Blanc JJ

doi

10.1016/j.pcad.2012.11.002

subject

Has Abstract

pub_date

2013-01-01 00:00:00

pages

418-24

issue

4

eissn

0033-0620

issn

1873-1740

pii

S0033-0620(12)00209-5

journal_volume

55

pub_type

杂志文章,评审
  • Update on Obesity and Obesity Paradox in Heart Failure.

    abstract::Obesity has reached epidemic proportions in most of the Westernized world. Overweightness and obesity adversely impact cardiac structure and function, including on both the right and, especially, left sides of the heart, with adverse affects on systolic and, especially, diastolic ventricular function. Therefore, it is...

    journal_title:Progress in cardiovascular diseases

    pub_type: 杂志文章,评审

    doi:10.1016/j.pcad.2015.12.003

    authors: Lavie CJ,Sharma A,Alpert MA,De Schutter A,Lopez-Jimenez F,Milani RV,Ventura HO

    更新日期:2016-01-01 00:00:00

  • Impact of obesity and weight loss on cardiac performance and morphology in adults.

    abstract::Obesity, particularly severe obesity is capable of producing hemodynamic alterations that predispose to changes in cardiac morphology and ventricular function. These include increased cardiac output, left ventricular hypertrophy and diastolic and systolic dysfunction of both ventricles. Facilitated by co-morbidities s...

    journal_title:Progress in cardiovascular diseases

    pub_type: 杂志文章,评审

    doi:10.1016/j.pcad.2013.09.003

    authors: Alpert MA,Omran J,Mehra A,Ardhanari S

    更新日期:2014-01-01 00:00:00

  • Inadequate physical activity and health care expenditures in the United States.

    abstract::This study estimates the percentage of health care expenditures in the non-institutionalized United States (U.S.) adult population associated with levels of physical activity inadequate to meet current guidelines. Leisure-time physical activity data from the National Health Interview Survey (2004-2010) were merged wit...

    journal_title:Progress in cardiovascular diseases

    pub_type: 杂志文章

    doi:10.1016/j.pcad.2014.08.002

    authors: Carlson SA,Fulton JE,Pratt M,Yang Z,Adams EK

    更新日期:2015-01-01 00:00:00

  • Comparative effects of lipid-lowering therapies.

    abstract::The pharmacologic regulation of lipid metabolism in patients with dyslipidemia is unequivocally associated with significant reductions in risk for cardiovascular morbidity and mortality. A number of therapeutic drug classes have been developed in an effort to ever more precisely and intensively modulate lipid metaboli...

    journal_title:Progress in cardiovascular diseases

    pub_type: 杂志文章,评审

    doi:10.1016/j.pcad.2004.04.007

    authors: Davidson MH,Toth PP

    更新日期:2004-09-01 00:00:00

  • New Concepts in Hypertension Management: A Population-Based Perspective.

    abstract::Hypertension (HTN) is the most common chronic disease in the U.S., and the standard model of office-based care delivery has yielded suboptimal outcomes, with approximately 50% of affected patients not achieving blood pressure (BP) control. Poor population-level BP control has been primarily attributed to therapeutic i...

    journal_title:Progress in cardiovascular diseases

    pub_type: 杂志文章,评审

    doi:10.1016/j.pcad.2016.09.005

    authors: Milani RV,Lavie CJ,Wilt JK,Bober RM,Ventura HO

    更新日期:2016-01-01 00:00:00

  • The contribution of the Framingham Heart Study to the prevention of cardiovascular disease: a global perspective.

    abstract::The Framingham Heart Study has been a trailblazer in the field of cardiovascular epidemiology. The wealth of novel scientific data that it has generated over 5 decades has made a significant contribution to cardiovascular disease (CVD) prevention in the United States and indirectly influenced global CVD prevention str...

    journal_title:Progress in cardiovascular diseases

    pub_type: 历史文章,杂志文章

    doi:10.1016/j.pcad.2010.01.001

    authors: Mendis S

    更新日期:2010-07-01 00:00:00

  • Transcatheter innovations in tricuspid regurgitation: Cardioband.

    abstract::Functional tricuspid regurgitation (FTR) has been neglected for a long time, however its prevalence and clinical relevance is not negligible. In presence of FTR, a certain quote of annular dilatation is present thus contributing to the mechanism of regurgitation. Historically, surgical annuloplasty has been the main t...

    journal_title:Progress in cardiovascular diseases

    pub_type: 杂志文章,评审

    doi:10.1016/j.pcad.2019.10.002

    authors: Mangieri A,Latib A

    更新日期:2019-01-01 00:00:00

  • Heart Failure Transitions of Care: A Pharmacist-Led Post-Discharge Pilot Experience.

    abstract:OBJECTIVE:To perform a pilot evaluation of a pharmacist-led, multidisciplinary transitional care clinic for heart failure (HF) patients. BACKGROUND:Transitions of care in HF should include: medication reconciliation, multidisciplinary care, early post-discharge follow-up, and prompt intervention on HF signs and sympto...

    journal_title:Progress in cardiovascular diseases

    pub_type: 杂志文章

    doi:10.1016/j.pcad.2017.08.005

    authors: Milfred-LaForest SK,Gee JA,Pugacz AM,Piña IL,Hoover DM,Wenzell RC,Felton A,Guttenberg E,Ortiz J

    更新日期:2017-01-01 00:00:00

  • Secondary analysis of clinical trials--a cautionary note.

    abstract::There is concern in published reports and reviews that patients are being harmed or denied effective treatment by the use of questionable results from secondary analyses of data from clinical trials. A well-reported secondary analysis must make clear to the reader the uncertainty of the result--so clear, in fact, that...

    journal_title:Progress in cardiovascular diseases

    pub_type: 杂志文章,评审

    doi:10.1016/j.pcad.2011.09.006

    authors: Marler JR

    更新日期:2012-01-01 00:00:00

  • Aortic pain.

    abstract::With the exception of the pain of acute aortic dissection, the thoracic aorta is not usually considered as a pain-producing organ. However, nineteenth century clinicians considered the aorta as a source of cardiovascular pain in the presence of autopsy-documented inflammatory aortitis, aortic aneurysms, and arterial h...

    journal_title:Progress in cardiovascular diseases

    pub_type: 杂志文章,评审

    doi:10.1016/s0033-0620(98)80004-2

    authors: Wooley CF,Sparks EH,Boudoulas H

    更新日期:1998-05-01 00:00:00

  • Heart failure in patients with preserved left ventricular systolic function: do digitalis glycosides have a role?

    abstract::It is being increasingly appreciated that a substantial number of patients with congestive heart failure (CHF) have relatively preserved systolic function. Although these individuals appear to have a somewhat better prognosis than those with low ejection fractions, they experience significant symptoms and frequently r...

    journal_title:Progress in cardiovascular diseases

    pub_type: 杂志文章,评审

    doi:10.1016/s0033-0620(98)80053-4

    authors: Massie BM,Abdalla I

    更新日期:1998-01-01 00:00:00

  • Tumor necrosis factor in congestive heart failure: a mechanism of disease for the new millennium?

    abstract::Tumor necrosis factor alpha (TNF-alpha), a protein belonging to the family of cytokines, is one of the leading mediators of the immune response to inflammation. Its widespread biological effects are modulated by two circulating binding proteins corresponding to the extracellular domain of the membrane receptors, namel...

    journal_title:Progress in cardiovascular diseases

    pub_type: 杂志文章,评审

    doi:10.1016/s0033-0620(98)80028-5

    authors: Ceconi C,Curello S,Bachetti T,Corti A,Ferrari R

    更新日期:1998-07-01 00:00:00

  • Coronary Disease and Modifying Cardiovascular Risk in Adult Congenital Heart Disease Patients: Should General Guidelines Apply?

    abstract::There are >1.4 million adult congenital heart disease (CHD; ACHD) patients living in the United States. Coronary artery disease (CAD) is at least as prevalent in ACHD patients as in the general population and has become a leading cause of their mortality. In the majority of cases, CAD in the ACHD population is driven ...

    journal_title:Progress in cardiovascular diseases

    pub_type: 杂志文章,评审

    doi:10.1016/j.pcad.2018.07.018

    authors: Awerbach JD,Krasuski RA,Camitta MGW

    更新日期:2018-01-01 00:00:00

  • Guidelines for the delivery and monitoring of high intensity interval training in clinical populations.

    abstract::High intensity interval training (HIIT) is now recognized in international clinical-based exercise guidelines as an appropriate and beneficial adjunct to moderate intensity continuous training. HIIT involves alternating periods of high intensity aerobic exercise with light recovery exercise or no exercise, allowing fo...

    journal_title:Progress in cardiovascular diseases

    pub_type: 杂志文章,实务指引,评审

    doi:10.1016/j.pcad.2019.01.004

    authors: Taylor JL,Holland DJ,Spathis JG,Beetham KS,Wisløff U,Keating SE,Coombes JS

    更新日期:2019-01-01 00:00:00

  • The Ideal Anticoagulation Strategy in ST-Elevation Myocardial Infarction.

    abstract::Heparin has been the principal anticoagulant in the management of ST-elevation myocardial infarction (STEMI) but has several limitations. Although glycoprotein IIb/IIIa inhibitors have been major adjuncts in previous years, in the era of novel P2Y12 receptor inhibitors they may have a greater role in bailout. Low mole...

    journal_title:Progress in cardiovascular diseases

    pub_type: 杂志文章,评审

    doi:10.1016/j.pcad.2015.08.007

    authors: Chandrasekhar J,Mehran R

    更新日期:2015-11-01 00:00:00

  • Consumer Health Informatics: Empowering Healthy-Living-Seekers Through mHealth.

    abstract::People are at risk from noncommunicable diseases (NCD) and poor health habits, with interventions like medications and surgery carrying further risk of adverse effects. This paper addresses ways people are increasingly moving to healthy living medicine (HLM) to mitigate such health threats. HLM-seekers increasingly le...

    journal_title:Progress in cardiovascular diseases

    pub_type: 杂志文章,评审

    doi:10.1016/j.pcad.2016.12.006

    authors: Faiola A,Holden RJ

    更新日期:2017-01-01 00:00:00

  • The role of cardiovascular magnetic resonance in patients with acute coronary syndromes.

    abstract::Cardiovascular magnetic resonance (CMR) imaging is a recognized technique for characterization of myocardial tissue in stable ischemic heart disease. In addition, CMR is emerging as a noninvasive imaging tool that can provide supporting information to guide treatment in acute coronary syndromes (ACSs). The advantages ...

    journal_title:Progress in cardiovascular diseases

    pub_type: 杂志文章,评审

    doi:10.1016/j.pcad.2011.09.001

    authors: Dall Armellina E,Choudhury RP

    更新日期:2011-11-01 00:00:00

  • How much should LDL cholesterol be lowered in secondary prevention? Clinical efficacy and safety in the era of PCSK9 inhibitors.

    abstract::There is a strong evidence that more marked lowering of low-density lipoprotein cholesterol (LDL-C) leads to progressively lower risk of cardiovascular disease (CVD) events. The evidence on validity of this hypothesis comes from epidemiological, genetic and clinical studies. The hypothesis "the lower the better" has b...

    journal_title:Progress in cardiovascular diseases

    pub_type: 杂志文章,评审

    doi:10.1016/j.pcad.2020.12.008

    authors: Cybulska B,Kłosiewicz-Latoszek L,Penson PE,Nabavi SM,Lavie CJ,Banach M,International Lipid Expert Panel (ILEP).

    更新日期:2020-12-28 00:00:00

  • Beta blocker treatment in heart failure.

    abstract::The sympathetic nervous system occupies a prominent role in heart failure both as a marker of severity of disease and also as an important factor in its progression. Beta blocker therapy, once thought heretical in heart failure, has consistently improved cardiac function and slowed progression of disease. Large clinic...

    journal_title:Progress in cardiovascular diseases

    pub_type: 杂志文章,评审

    doi:10.1053/pcad.1999.0410301

    authors: Carson PE

    更新日期:1999-01-01 00:00:00

  • Biology of ischemic cerebral cell death.

    abstract::With the approval of alteplase (tPA) therapy for stroke, it is likely that combination therapy with tPA to restore blood flow, and agents like glutamate receptor antagonists to halt or reverse the cascade of neuronal damage, will dominate the future of stroke care. The authors describe events and potential targets of ...

    journal_title:Progress in cardiovascular diseases

    pub_type: 杂志文章,评审

    doi:10.1016/s0033-0620(99)70002-2

    authors: Small DL,Morley P,Buchan AM

    更新日期:1999-11-01 00:00:00

  • Thyroid hormone therapy in cardiovascular disease.

    abstract::The relationship between thyroid disease states and cardiovascular hemodynamics is well recognized. Although the long-term effects of thyroid hormone are thought to result from changes in myocardial gene expression, attention has recently focused on acute, non-nuclear-mediated actions of L-triidothyronine (T3), the bi...

    journal_title:Progress in cardiovascular diseases

    pub_type: 杂志文章,评审

    doi:10.1016/s0033-0620(96)80017-x

    authors: Klemperer JD,Ojamaa K,Klein I

    更新日期:1996-01-01 00:00:00

  • Mechanisms of atrial fibrillation: lessons from studies in patients.

    abstract::Recent clinical studies performed in human subjects have provided important clues that improved our understanding of the mechanisms of atrial fibrillation (AF) and facilitated development of new treatment strategies. When analyzed together, these studies confirm the complexity and multifactorial nature of AF. Because ...

    journal_title:Progress in cardiovascular diseases

    pub_type: 杂志文章,评审

    doi:10.1016/j.pcad.2005.06.003

    authors: Oral H

    更新日期:2005-07-01 00:00:00

  • The use of echocardiography for quantitative evaluation of left ventricular function.

    abstract::Echocardiography is a valuable technique for the diagnosis and serial follow-up of patients with impaired cardiac function. It is subject to certain limitations due to the assumptions inherent in deriving ventricular volume from a one-dimensional measurement and must be interpreted with caution in cases of suspected r...

    journal_title:Progress in cardiovascular diseases

    pub_type: 杂志文章,评审

    doi:10.1016/0033-0620(78)90018-x

    authors: Mason SJ,Fortuin NJ

    更新日期:1978-09-01 00:00:00

  • Electrophysiological basis of QT dispersion measurements.

    abstract::Dispersion of ventricular repolarization is a now widely used term describing nonhomogeneous recovery of excitability or heterogeneity of ventricular repolarization. It is usually expressed as the difference or the range of various repolarization measurements obtained from a heart. Experimentally, an increased dispers...

    journal_title:Progress in cardiovascular diseases

    pub_type: 杂志文章,评审

    doi:10.1053/pcad.2000.0420311

    authors: Franz MR,Zabel M

    更新日期:2000-03-01 00:00:00

  • Reducing infarct size in the setting of acute myocardial infarction.

    abstract::Acute myocardial infarction is caused by coronary occlusion, and the mainstay of treatment has become reperfusion by either coronary angioplasty with possible stenting or surgical bypass grafting. Unfortunately, reperfusion can seldom be done soon enough to prevent infarction. Thus, the search for effective cardioprot...

    journal_title:Progress in cardiovascular diseases

    pub_type: 杂志文章,评审

    doi:10.1016/j.pcad.2006.02.005

    authors: Downey JM,Cohen MV

    更新日期:2006-03-01 00:00:00

  • Acute mountain sickness: pathophysiology, prevention, and treatment.

    abstract::Barometric pressure falls with increasing altitude and consequently there is a reduction in the partial pressure of oxygen resulting in a hypoxic challenge to any individual ascending to altitude. A spectrum of high altitude illnesses can occur when the hypoxic stress outstrips the subject's ability to acclimatize. Ac...

    journal_title:Progress in cardiovascular diseases

    pub_type: 杂志文章,评审

    doi:10.1016/j.pcad.2010.02.003

    authors: Imray C,Wright A,Subudhi A,Roach R

    更新日期:2010-05-01 00:00:00

  • Coronary heart disease: the female heart is vulnerable.

    abstract::During the past decade, an overall theme has emerged, validating the exploration of gender-based differences in coronary heart disease (CHD) as a basis for clinical strategies to improve outcomes for women. Underrepresentation of women in most of CHD and lack of gender-specific reporting in many clinical trials contin...

    journal_title:Progress in cardiovascular diseases

    pub_type: 杂志文章,评审

    doi:10.1016/j.pcad.2003.08.003

    authors: Wenger NK

    更新日期:2003-11-01 00:00:00

  • Pharmacological approaches for the prevention of restenosis after percutaneous coronary intervention.

    abstract::A large number of drug trials for prevention of restenosis have been conducted with many showing little or conflicting benefit. Antiplatelets such as aspirin, ticlopidine and thromboxane A2 receptor inhibitors have not shown a clear benefit. Similarly, antithrombotics, either acting indirectly such as heparin, or as d...

    journal_title:Progress in cardiovascular diseases

    pub_type: 杂志文章,评审

    doi:10.1016/s0033-0620(97)80006-0

    authors: Lefkovits J,Topol EJ

    更新日期:1997-09-01 00:00:00

  • Advanced Imaging Techniques for Mitral Regurgitation.

    abstract::Mitral regurgitation (MR) is one of the most commonly encountered valvular lesions in clinical practice. MR can be either primary (degenerative) or secondary (functional) depending on the etiology of MR and the pathology of the mitral valve (MV). Echocardiography is the primary diagnostic tool for MR and is key in det...

    journal_title:Progress in cardiovascular diseases

    pub_type: 杂志文章,评审

    doi:10.1016/j.pcad.2018.10.001

    authors: Quien MM,Vainrib AF,Freedberg RS,Bamira DG,Benenstein RJ,Williams MR,Saric M

    更新日期:2018-01-01 00:00:00

  • Curing breast cancer and killing the heart: A novel model to explain elevated cardiovascular disease and mortality risk among women with early stage breast cancer.

    abstract::Due to advances in prevention, early detection and treatment, early breast cancer mortality has decreased by nearly 40% during the last four decades. Yet, the risk of cardiovascular disease (CVD) mortality is significantly elevated following a breast cancer diagnosis, and it is a leading cause of death in this populat...

    journal_title:Progress in cardiovascular diseases

    pub_type: 杂志文章,评审

    doi:10.1016/j.pcad.2019.02.002

    authors: Kirkham AA,Beaudry RI,Paterson DI,Mackey JR,Haykowsky MJ

    更新日期:2019-01-01 00:00:00